Home › Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Sep 06, 2016

NEW YORK (GenomeWeb) – Alere today filed its financial results for the second quarter of 2016, reporting a 2 percent decrease in revenues year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

What's Popular?

In Molecular Diagnostics

  1. Danaher Q2 Revenues Grow 6 Percent; MDx Product Line Shut Down

  2. Startup SpinDiag Raises €1.6M in Seed Funding

  3. Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges

  4. NanoVelcro Microchips Can Capture Fetal Cells from Maternal Blood for Prenatal Genetic Testing

    Premium

  5. Abbott Dx Revenues Rise 4 Percent in Q2 on Strong Core Lab and Point-of-Care Growth

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.